Jay Bhattacharya has spent years railing against the National Institutes of Health. What happens when he runs it?
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.
Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in ...
The move comes two days after 25% tariffs on nearly all goods from the two countries took effect. The exemptions apply to about half of all imports from Mexico and 38% of goods from Canada and will ...
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese ...
“The menopause transition specifically might be an important key to help us unlock the biology of Alzheimer’s disease, and ...
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...
President Trump’s pick to lead the National Institutes of Health (NIH) faced questions from senators Wednesday on his plans for vaccine research, ideas for pushing down drug prices, and response ...
At his senate confirmation hearing today, Dr Jay Bhattacharya heralded the National Institutes of Health as the 'crown jewels ...
23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results